Skip to main content
Advertisement
Advertisement

VKTX

VKTX logo

Viking Therapeutics, Inc

28.51
USD
Sponsored
+0.78
+2.81%
Oct 09, 15:59 UTC -4
Closed
exchange

After-Market

28.55

+0.04
+0.14%

VKTX Earnings Reports

Positive Surprise Ratio

VKTX beat 23 of 43 last estimates.

53%

Next Report

Date of Next Report
Oct 28, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/
-$1.09
Implied change from Q2 26 (Revenue/ EPS)
--
/
-0.91%
Implied change from Q3 25 (Revenue/ EPS)
--
/
+34.57%

Viking Therapeutics, Inc earnings per share and revenue

On Jul 29, 2026, VKTX reported earnings of -1.10 USD per share (EPS) for Q2 26, beating the estimate of -1.27 USD, resulting in a 13.52% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -0.96% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 10 analysts forecast an EPS of -1.09 USD, with revenue projected to reach -- USD, implying an decrease of -0.91% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Inventiva S.A. - ADR
Report Date
Sep 28, 2026 For Q2 26
Estimate
-$0.37
Actual
-$0.25
Surprise
+33.55%
logo
Palatin Technologies, Inc. Common Stock
Report Date
Sep 28, 2026 For Q4 26
Estimate
-$1.21
Actual
-$1.11
Surprise
+8.42%
FAQ
For Q2 2026, Viking Therapeutics, Inc reported EPS of -$1.10, beating estimates by 13.52%, and revenue of $0.00, 0% as expectations.
The stock price moved down -0.96%, changed from $33.43 before the earnings release to $33.11 the day after.
The next earning report is scheduled for Oct 28, 2026.
Based on 10 analysts, Viking Therapeutics, Inc is expected to report EPS of -$1.09 and revenue of -- for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement